financetom
Business
financetom
/
Business
/
Update: Market Chatter: CVS Health Defers Offering COVID-19 Vaccines in 16 States
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Market Chatter: CVS Health Defers Offering COVID-19 Vaccines in 16 States
Aug 29, 2025 6:34 AM

09:27 AM EDT, 08/29/2025 (MT Newswires) -- (Updates with spokesperson statement in the fourth and fifth paragraphs.)

CVS Health ( CVS ) is currently holding off on offering COVID-19 vaccines in 16 states due to the "current regulatory environment," The New York Times reported Friday, citing company spokesperson Amy Thibault.

The company is waiting until the Advisory Committee on Immunization Practices recommends the vaccines before offering them nationwide, as pharmacists in some states are not allowed to administer them without the endorsement, the spokesperson told the news outlet.

According to the report, the states where CVS is not currently offering the vaccines are Arizona, Colorado, Florida, Georgia, Kentucky, Louisiana, Maine, Massachusetts, Nevada, New Mexico, New York, North Carolina, Pennsylvania, Utah, Virginia and West Virginia, along with the District of Columbia.

In an email to MT Newswires, Thibault said CVS pharmacies can administer COVID-19 vaccines with an authorized prescription, depending on the patient's age, in all 16 states except Massachusetts, Nevada, and New Mexico. Based on the current regulatory environment, CVS Pharmacy is offering Covid-19 vaccinations in Alaska, Alabama, Arkansas, California, Connecticut, Delaware, Hawaii, Iowa, Idaho, Illinois, Indiana, Kansas, Maryland, Michigan, Minnesota, Montana, Missouri, Mississippi, Nebraska, North Dakota, New Hampshire, New Jersey, Ohio, Oklahoma, Oregon, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Vermont, Washington, Wisconsin and Wyoming, the spokesperson said.

"We expect to receive the updated 2025-2026 COVID-19 vaccines in the coming days," Thibault also said.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alnylam Pharmaceuticals Insider Sold Shares Worth $422,144, According to a Recent SEC Filing
Alnylam Pharmaceuticals Insider Sold Shares Worth $422,144, According to a Recent SEC Filing
Nov 27, 2024
05:29 PM EST, 11/27/2024 (MT Newswires) -- Pushkal Garg, CMO & EVP Dev & Med Affairs, on Nov. 25 and Nov. 26, sold 1,682 shares in Alnylam Pharmaceuticals ( ALNY ) for $422,144. Following the Form 4 filing with the SEC, Garg has control over a total of 18,138 shares of the company, with 17,457 shares held directly and 681...
Alnylam Pharmaceuticals Insider Sold Shares Worth $1,309,853, According to a Recent SEC Filing
Alnylam Pharmaceuticals Insider Sold Shares Worth $1,309,853, According to a Recent SEC Filing
Nov 27, 2024
05:29 PM EST, 11/27/2024 (MT Newswires) -- Yvonne Greenstreet, Director, Chief Executive Officer, on Nov. 25 and Nov. 26, sold 5,219 shares in Alnylam Pharmaceuticals ( ALNY ) for $1,309,853. Following the Form 4 filing with the SEC, Greenstreet has control over a total of 79,287 shares of the company, with 78,880 shares held directly and 407 controlled indirectly. SEC...
Nerdy Insider Bought Shares Worth $432,000, According to a Recent SEC Filing
Nerdy Insider Bought Shares Worth $432,000, According to a Recent SEC Filing
Nov 27, 2024
05:23 PM EST, 11/27/2024 (MT Newswires) -- Charles K. Cohn, 10% Owner, Director, Chief Executive Officer, on Nov. 25, executed a purchase for 300,000 shares in Nerdy ( NRDY ) for $432,000. Following the Form 4 filing with the SEC, Cohn has control over a total of 48,388,009 shares of the company, with 9,258,298 shares held directly and 39,129,711 controlled...
Exco Technologies Reports a Lower Fiscal Fourth-Quarter Profit as Sales Drop
Exco Technologies Reports a Lower Fiscal Fourth-Quarter Profit as Sales Drop
Nov 27, 2024
05:28 PM EST, 11/27/2024 (MT Newswires) -- Exco Technologies ( EXCOF ) after trade Wednesday said its fiscal fourth-quarter profit fell on weaker sales. The auto parts and casting company said it earned $7.7 million, or $0.20 per share, down from $9.2 million, or $0.24, in the same quarter last year. Sales for the quarter ended Sept. 30 fell 3%...
Copyright 2023-2025 - www.financetom.com All Rights Reserved